Policy and Guidelines for Interactions between the Stanford School of Medicine, Stanford Health Care, and Lucile Packard Children’s Hospital Stanford with the Pharmaceutical, Biotech, Medical Device, and Hospital and Research Equipment and Supplies Industries (“Industry”).
Purpose of Policy
The purpose of this policy is to establish guidelines for interactions with Industry representatives throughout Stanford Medicine, which is composed of the Stanford School of Medicine, Stanford Health Care and the Lucile Packard Children’s Hospital Stanford. Interactions with Industry occur in a variety of contexts, including marketing of new pharmaceutical products, medical devices, and hospital and research equipment and supplies on-site, on-site training of newly purchased devices, the development of new devices, educational support of medical students and trainees, and continuing medical education. Faculty and trainees also participate in interactions with Industry off campus and in scholarly publications in a variety of circumstances including consulting activities of various sorts. Many aspects of these interactions are very positive and important for promoting the educational, clinical and research missions of Stanford Medicine and for translating knowledge and expertise from the faculty to society. However, these interactions must be ethical and cannot create conflicts of interest (COI) that could endanger patient safety, data integrity, the integrity of our education and training programs, or the reputation of either the faculty member or the institution. Individuals must consciously and actively divorce clinical care decisions from any perceived or actual benefits expected from any company. It is unacceptable for patient care decisions to be influenced by the possibility of personal financial gain. See policy for Conflicts of Interest in Clinical Care.
Statement of Policy
It is the policy of the Stanford School of Medicine, Stanford Health Care and the Lucile Packard Children’s Hospital Stanford that interactions with Industry should be conducted so as to avoid or minimize conflicts of interest. When conflicts of interest do arise they must be addressed appropriately, as described herein.
Scope of Policy
This policy incorporates the following types of interactions with Industry.
I. Gifts and compensation
II. Site access by sales and marketing representatives
III. Provision of scholarships and other educational funds to students and trainees
IV. Support for educational and other professional activities
V. Disclosure of relationships with industry
VI. Training of students, trainees, and staff regarding potential conflict of interest in industry interactions
Specific policies concerning conflict of interest related to research activities are coverd by the Faculty Policy on Conflicts of Commitment and Interest, Conflict of Interest and Commitment for Academic Staff, and the Staff Conflict of Interest Policy.
For purposes of this policy, "faculty" is defined as all members of the Academic Council [University Tenure Line, Non-tenure Line (Research), Non-tenure Line (Teaching) and Non-tenure Line (Clinical)], the Medical Center Line, the Clinician Educator Line and Adjunct Clinical Faculty. All faculty are required to comply with this policy at all times whether they are full time, part time, or active emeriti.
In addition, Academic Council and Medical Center Line faculty must all comply with the Faculty Policy on Conflict of Commitment and Interest. Clinician Educator Line faculty must comply with the Staff Policy on Conflict of Interest and Commitment. Additional information specifically related to industry interactions involving ACCME and accredited educational activities (also called CME) can be found here. This policy also does not address relationships with other entities that are not encompassed by "Industry".
This policy will be modified as necessary in the future to be in compliance with requirements of external agencies.
Date of implementation: October 1, 2006
Revised as of July 1, 2014